Genome‑wide CRISPR screens in primary human T cells reveal human genes that promote or block HIV infection, uncovering potent ...
As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T cells — which have lost their cancer-fighting oomph — consume this lactic acid ...
We owe a lot to tissue resident memory T cells (T RM). These specialized immune cells are among the body's first responders to disease. Rather than coursing through the bloodstream-as many T cells ...
It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...
SAN DIEGO - An innovative type of CAR T cell therapy, called KIR-CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of ...
The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen ...
(MEMPHIS, Tenn. – August 20, 2024) Scientists at St. Jude Children’s Research Hospital and Washington University School of Medicine have discovered why the flu vaccine can perform poorly. They found ...
As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Newly reported research by scientists at the University of Pittsburgh and UPMC Hillman ...
SAN FRANCISCO -- The response rate in metastatic gastroesophageal cancer improved by a relative 50% when patients received experimental activated T cells in addition to standard therapy, according to ...
Blocking a protein that imports lactic acid, a metabolic byproduct of cancer cells, reinvigorated exhausted T cells and led to improved tumor control in mouse models of cancer, according to a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results